Therefore, this study aimed to investigate the effects of SH3PXD2A-AS1 on DDP resistance in NSCLC and the associated mechanism, with the goal of identifying a possible therapeutic approach for NSCLC. This evidence concerns the gene SH3PXD2A and non-small cell lung carcinoma.